Mechanistic studies reveal that SFN significantly downregulates programmed death-ligand 1 (PD-L1) expression on tumor cells through multiple mechanisms, including direct covalent modification of cysteine residues on STAT1, which inhibits its transcriptional activity and blocks IFN--induced PD-L1 expression ( The immunomodulatory effects of SFN extend to comprehensive reprogramming of immune cell populations within the tumor niche
Common : Nausea (up to 44%), vomiting, diarrhea, constipation Less common : Fatigue, dyspepsia, bloating, dizziness Rare : Cholelithiasis, acute pancreatitis Serious : Risk of thyroid tumors (animal data), kidney impairment due to dehydration Proper storage is critical to maintaining the products efficacy
Key takeaways Wegovy (semaglutide) is an injectable prescription weight loss medication for people 12 years and older
In addition to glycemic control and statins, monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9), heat shock proteins60/65 (HSP60/65), and ApoB are expected to improve AS by targeting